We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current PASG market cap is 40.76M. The company's latest EPS is USD -1.6524 and P/E is -0.40.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -23.28M | -18.45M | -18.05M | -16.94M | -15.91M |
| Net Income | -27.11M | -16.76M | -16.71M | -15.99M | -19.34M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -37.19M | -112.9M | -185.73M | -138.39M | -103M |
| Net Income | -45.63M | -112.23M | -185.39M | -136.13M | -102.06M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 169.26M | 150.55M | 140.53M | 125.39M | 111.75M |
| Total Liabilities | 42.98M | 39.26M | 35.65M | 34.84M | 39.04M |
| Total Equity | 126.28M | 111.28M | 104.88M | 90.56M | 72.72M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 178.61M | 328.01M | 355.08M | 243.55M | 150.55M |
| Total Liabilities | 4.26M | 23.29M | 36.42M | 42.18M | 39.26M |
| Total Equity | -56.25M | 304.71M | 318.66M | 201.37M | 111.28M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -58.75M | -78.26M | -18.93M | -32.07M | -39.51M |
| Investing | 57.64M | 65.24M | 25.25M | 26.3M | 41.27M |
| Financing | 89k | 135k | 8.74M | 8.83M | 8.83M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -39.9M | -80.52M | -126.88M | -118.21M | -78.26M |
| Investing | -1.69M | -172.11M | -45.81M | 25.2M | 65.24M |
| Financing | 175.6M | 228.75M | 166.66M | -1.35M | 135k |
| Market Cap | 40.76M |
| Price to Earnings Ratio | -0.40 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.88 |
| Price to Book Ratio | 0.37 |
| Dividend Yield | - |
| Shares Outstanding | 61.77M |
| Average Volume (1 week) | 921.82k |
| Average Volume (1 Month) | 1.38M |
| 52 Week Change | -29.55% |
| 52 Week High | 1.79 |
| 52 Week Low | 0.451 |
| Spread (Intraday) | 0.04 (5.88%) |
| Company Name | Passage Bio Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.passagebio.com/home/default.aspx |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
